COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 1733: Articles 17321-17330  | Next

Real-time analysis of a mass vaccination effort via an Artificial Intelligence platform confirms the safety of FDA-authorized COVID-19 vaccines
McMurry, R., Lenehan, P. J., Awasthi, S., Silvert, E., Puranik, A., Pawlowski, C., Venkatakrishnan, A., Anand, P., Agarwal, V., OHoro, J. C., Gores, G. J., Williams, A. W., Badley, A. D., Halamka, J., Virk, A., Smith, M. D., Carlson, K., Doddahonnaiah, D., Metzger, A., Kayal, N., Berner, G., Ramudu, E., Carpenter, C., Wagner, T., Rajasekharan, A., Soundararajan, V.
10.1101/2021.02.20.21252134 — Posted: 2021-02-23
Temporal and geographical variation of COVID-19 in-hospital fatality rate in Brazil
Portella, T. P., Mortara, S. R., Lopes, R., Sanchez-Tapia, A., Donalisio, M. R., Castro, M. C., Venturieri, V. R., Estevam, C. G., Ribeiro, A. F., Coutinho, R. M., Veras, M. A. S. M., Prado, P. I., Kraenkel, R. A.
10.1101/2021.02.19.21251949 — Posted: 2021-02-23
The early dynamics of the SARS-CoV-2 epidemic in Portugal
Borges, V., Isidro, J., Trovao, N. S., Duarte, S., Cortes-Martins, H., Martiniano, H., Gordo, I., Leite, R., Vieira, L., Portuguese network for SARS-CoV-2 genomics (Consortium), , Guiomar, R., Gomes, J. P.
10.1101/2021.02.22.21252216 — Posted: 2021-02-23
An allele-specific primer extension assay to quantify the proportion of B.1.1.7-specific SARS-CoV-2 RNA in wastewater
Graber, T. E., Mercier, E., D'Aoust, P. M., Hoang, H.-D., Tian, X., Tasneem, S., Bhatnagar, K., Delatolla, R.
10.1101/2021.02.22.21252041 — Posted: 2021-02-23
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests.
Stohr, J. J. J. M., Zwart, V. F., Goderski, G., Meijer, A., Nagel-Imming, C. R. S., Kluytmans-van den Bergh, M. F. Q., Pas, S. D., van den Oetelaar, F., Hellwich, M., Gan, K. H., Rietveld, A., Verweij, J. J., Murk, J. L., van den Bijllaardt, W., kluytmans, J. J. A. J. W.
10.1101/2021.02.21.21252153 — Posted: 2021-02-23
Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
Gurevich, Y., Ram, Y., Hadany, L.
10.1101/2021.02.20.21252133 — Posted: 2021-02-23
REACT-1 round 9 interim report: downward trend of SARS-CoV-2 in England inFebruary 2021 but still at high prevalence
Riley, S., Walters, C. E., Wang, H., Eales, O., Haw, D., Ainslie, K. E. C., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.02.18.21251973 — Posted: 2021-02-23
Smelling Household-Odorants Effectively Screens for COVID-19
snitz, k., Honigstein, D., Weisgross, R., Ravia, A., Mishor, E., Perl, O., Karagach, S., Medhanie, A., Harel, N., Shushan, S., Roth, Y., Iravani, B., Arshamian, A., Ernst, G., Okamoto, M., Mainen, Z., Poo, C., Bonacchi, N., Monteleone, E., Dinnella, C., Spinelli, S., Marino-Sanchez, F., Ferdenzi, C., Smeets, M., Touhara, K., Bensafi, M., Hummel, T., Lundstrom, J. N., Sobel, N.
10.1101/2021.02.18.21251422 — Posted: 2021-02-23
Heterogeneity in COVID-19 severity patterns among age-gender groups: an analysis of 778 692 Mexican patients through a meta-clustering technique
Zhou, L., Romero, N., Martinez Miranda, J., Conejero, J. A., Garcia-Gomez, J. M., Saez, C.
10.1101/2021.02.21.21252132 — Posted: 2021-02-23
Evolving Infection Paradox of SARS-CoV-2: Fitness Costs Virulence?
Alam, A. S. M. R. U., Islam, O. K., Hasan, M. S., Islam, M. R., Mahmud, S., AlEmran, H. M., Jahid, I. K., Crandall, K. A., Hossain, M. A.
10.1101/2021.02.21.21252137 — Posted: 2021-02-23 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).